Frontier Capital Management CO LLC Abiomed Inc Transaction History

Frontier Capital Management CO LLC

$9.96 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $19,884 - $24,719	-82 Reduced 0.47%	17,312 $4.25 Million
Q2 2022 Jul 20, 2022	SELL	$224.73 - $338.64 $109,892 - $165,594	-489 Reduced 2.73%	17,394 $4.31 Million
Q1 2022 Apr 14, 2022	SELL	$277.25 - $366.29 $18,298 - $24,175	-66 Reduced 0.37%	17,883 $5.92 Million
Q4 2021 Jan 19, 2022	SELL	$300.63 - $371.35 $74,556 - $92,094	-248 Reduced 1.36%	17,949 $6.45 Million
Q3 2021 Oct 19, 2021	SELL	$310.19 - $376.2 $178,669 - $216,691	-576 Reduced 3.07%	18,197 $5.92 Million
Q2 2021 Aug 09, 2021	BUY	$262.71 - $351.17 $1.68 Million - $2.25 Million	6,397 Added 51.69%	18,773 $5.86 Million
Q1 2021 May 13, 2021	SELL	$285.92 - $355.13 $274,769 - $341,279	-961 Reduced 7.21%	12,376 $3.95 Million
Q4 2020 Jan 19, 2021	SELL	$251.88 - $324.2 $405,023 - $521,313	-1,608 Reduced 10.76%	13,337 $4.32 Million
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $2.26 Million - $2.81 Million	-8,874 Reduced 37.26%	14,945 $4.14 Million
Q2 2020 Jul 17, 2020	BUY	$141.4 - $257.09 $386,163 - $702,112	2,731 Added 12.95%	23,819 $5.75 Million
Q1 2020 Apr 16, 2020	SELL	$130.51 - $196.01 $24,666 - $37,045	-189 Reduced 0.89%	21,088 $3.06 Million
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $23.4 Million - $32.8 Million	-146,914 Reduced 87.35%	21,277 $3.63 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $5.01 Million - $7.96 Million	-28,493 Reduced 14.49%	168,191 $29.9 Million
Q2 2019 Aug 14, 2019	BUY	$250.96 - $284.94 $2.91 Million - $3.3 Million	11,597 Added 6.27%	196,684 $51.2 Million
Q1 2019 May 07, 2019	BUY	$276.39 - $362.25 $1.59 Million - $2.08 Million	5,755 Added 3.21%	185,087 $52.9 Million
Q4 2018 Jan 25, 2019	BUY	$281.08 - $444.25 $22.6 Million - $35.8 Million	80,540 Added 81.52%	179,332 $58.3 Million
Q3 2018 Oct 30, 2018	BUY	$354.53 - $449.75 $2.74 Million - $3.48 Million	7,734 Added 8.49%	98,792 $44.4 Million
Q2 2018 Aug 03, 2018	BUY	$278.07 - $446.21 $15.3 Million - $24.6 Million	55,049 Added 152.88%	91,058 $37.2 Million
Q1 2018 Apr 30, 2018	SELL	$192.49 - $295.85 $2.84 Million - $4.37 Million	-14,771 Reduced 29.09%	36,009 $10.5 Million
Q4 2017 Jan 18, 2018	SELL	$168.78 - $199.74 $11.3 Million - $13.4 Million	-66,859 Reduced 56.83%	50,780 $9.52 Million
Q3 2017 Oct 31, 2017	BUY	$145.39 - $168.6 $17.1 Million - $19.8 Million	117,639	117,639 $19.8 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account